Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
13.1M
-
Number of holders
-
119
-
Total 13F shares, excl. options
-
13.4M
-
Shares change
-
+1.7M
-
Total reported value, excl. options
-
$1.08B
-
Value change
-
+$144M
-
Put/Call ratio
-
4.58
-
Number of buys
-
90
-
Number of sells
-
-36
-
Price
-
$80.86
Significant Holders of EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) as of Q2 2015
133 filings reported holding EGRX - EAGLE PHARMACEUTICALS, INC. - Common Stock as of Q2 2015.
EAGLE PHARMACEUTICALS, INC. - Common Stock (EGRX) has 119 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.4M shares
.
Largest 10 shareholders include ProQuest Associates IV LLC (4.78M shares), Consonance Capital Management LP (1.18M shares), JW Asset Management, LLC (817K shares), JANUS CAPITAL MANAGEMENT LLC (785K shares), Park West Asset Management LLC (504K shares), Ranger Investment Management, L.P. (456K shares), STATE STREET CORP (438K shares), GENERAL ELECTRIC CO (337K shares), Allianz Asset Management AG (328K shares), and VANGUARD GROUP INC (315K shares).
This table shows the top 119 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.